WO2014125159A1 - Improvements in heart activity monitoring during physical exercise - Google Patents

Improvements in heart activity monitoring during physical exercise Download PDF

Info

Publication number
WO2014125159A1
WO2014125159A1 PCT/FI2013/050175 FI2013050175W WO2014125159A1 WO 2014125159 A1 WO2014125159 A1 WO 2014125159A1 FI 2013050175 W FI2013050175 W FI 2013050175W WO 2014125159 A1 WO2014125159 A1 WO 2014125159A1
Authority
WO
WIPO (PCT)
Prior art keywords
heart activity
phase
activity measurement
measurement signal
signal
Prior art date
Application number
PCT/FI2013/050175
Other languages
French (fr)
Inventor
Elias Pekonen
Juhani Kemppainen
Original Assignee
Polar Electro Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Polar Electro Oy filed Critical Polar Electro Oy
Priority to EP22217142.3A priority Critical patent/EP4179966A1/en
Priority to US14/767,225 priority patent/US11534075B2/en
Priority to PCT/FI2013/050175 priority patent/WO2014125159A1/en
Priority to EP13709954.5A priority patent/EP2956051B1/en
Publication of WO2014125159A1 publication Critical patent/WO2014125159A1/en
Priority to US17/992,625 priority patent/US20230091163A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/02Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • A61B5/024Detecting, measuring or recording pulse rate or heart rate
    • A61B5/0245Detecting, measuring or recording pulse rate or heart rate by using sensing means generating electric signals, i.e. ECG signals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/08Detecting, measuring or recording devices for evaluating the respiratory organs
    • A61B5/0816Measuring devices for examining respiratory frequency
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/24Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
    • A61B5/316Modalities, i.e. specific diagnostic methods
    • A61B5/318Heart-related electrical modalities, e.g. electrocardiography [ECG]
    • A61B5/346Analysis of electrocardiograms
    • A61B5/349Detecting specific parameters of the electrocardiograph cycle
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/24Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
    • A61B5/316Modalities, i.e. specific diagnostic methods
    • A61B5/318Heart-related electrical modalities, e.g. electrocardiography [ECG]
    • A61B5/346Analysis of electrocardiograms
    • A61B5/349Detecting specific parameters of the electrocardiograph cycle
    • A61B5/352Detecting R peaks, e.g. for synchronising diagnostic apparatus; Estimating R-R interval
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/68Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
    • A61B5/6801Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be attached to or worn on the body surface
    • A61B5/6813Specially adapted to be attached to a specific body part
    • A61B5/6823Trunk, e.g., chest, back, abdomen, hip
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/72Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7203Signal processing specially adapted for physiological signals or for diagnostic purposes for noise prevention, reduction or removal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/72Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7235Details of waveform analysis
    • A61B5/7253Details of waveform analysis characterised by using transforms
    • A61B5/726Details of waveform analysis characterised by using transforms using Wavelet transforms

Definitions

  • the invention relates to the field of training devices and, particularly to training devices monitoring heart activity of a user during a physical exercise.
  • Such training devices typically comprise electrodes that are placed into contact with the user's skin, and they measure a heart activity signal such as an electrocardiogram (ECG) signal non-invasively from the user's skin by using electric sensors, for example.
  • ECG electrocardiogram
  • Figure 1 illustrates an exercise monitoring system according to an embodiment of the invention
  • Figure 2 illustrates a flow diagram of a process for monitoring the phase of a heart activity measurement signal measured from the user's body during a physical exercise
  • Figure 3 illustrates a circuitry for extracting a phase component from the heart activity measurement signal according to an embodiment of the invention
  • Figure 4 illustrates a phase diagram and phases of a QRS complex waveform
  • FIGS. 5A to 5C illustrate the heart activity measurement signal and its components
  • Figure 6 illustrates a flow diagram of a process for determining a physiological parameter from the phase component of the heart activity measurement signal according to an embodiment of the invention
  • Figures 7A to 7C illustrate the heart activity measurement signal and its components with an interference signal component
  • Figure 8 illustrates a flow diagram of a process for detecting the interference signal components from the phase component of the heart activity measurement signal according to an embodiment of the invention
  • Figures 9A and 9B illustrate correlation between deviation of R-R intervals and phase behaviour of the heart activity measurement signal
  • Figure 10 illustrates a flow diagram of a process for determining a correction factor for computation of a performance metric from the phase component of the heart activity measurement signal according to an embodiment of the invention
  • Figure 1 1 illustrates a flow diagram of a process for computing a phase of a QRS complex waveform from the phase component of the heart activity measurement signal according to an embodiment of the invention
  • Figure 12 illustrates an embodiment of a measurement configuration for measuring the heart activity of the user
  • Figure 13 illustrates a flow diagram of a process for determining an optimal measurement configuration from the phase component of the heart activity measurement signal according to an embodiment of the invention
  • FIG. 14 illustrates phase behaviour of heart activity measurement signals
  • Figure 15 illustrates a flow diagram of a process for instructing the user to adjust the measurement configuration on the basis of analysing the phase component of the heart activity measurement signal according to an embodiment of the invention
  • Figure 16 illustrates a flow diagram of a process for monitoring deviation of the phase component of the heart activity measurement signal and instructing the user accordingly according to an embodiment of the invention.
  • Figure 17 illustrates a block diagram of an exercise monitoring apparatus according to an embodiment of the invention.
  • Figure 1 illustrates an embodiment of a personal training system comprising a sensor device 10 configured to measure heart activity signals from a user's 1 1 body.
  • the sensor device 10 may comprise one or a plurality of skin electrodes coupled to the user's 1 1 skin.
  • the sensor device 10 may be based on detection of an electrocardiogram (ECG) signal from the user's 1 1 skin.
  • ECG electrocardiogram
  • the heart activity measurement signals measured from the user's body may comprise the ECG signal being detected and, possibly, noise and interference components.
  • the sensor device 10 may further comprise a wireless communication circuitry configured to transmit measured heart activity measurement signals to another device, e.g. a user interface device 12, 14.
  • the user interface device 12, 14 may be configured to process the received heart activity measurement signals and to illustrate training processed from the heart activity measurement signals to the user 1 1 via a display unit, for example.
  • the user interface unit device a wrist device 12.
  • the user interface device is a portable computer 14 such as a mobile phone or a tablet computer.
  • Embodiments of the invention relate to monitoring properties of the heart activity measurement signals measured from the user's 1 1 skin.
  • the embodiments may be carried out in any one of the above-described devices 10, 12, 14 or in any other device acquiring the heart activity measurement signals.
  • the devices 10, 12, 14 may collectively be referred to as exercise monitoring apparatuses.
  • FIG. 2 illustrates a method for processing a heart activity measurement signal in such an exercise monitoring apparatus.
  • the heart activity measurement signal of a user 1 1 is acquired during a physical exercise performed by the user in block 200.
  • the heart activity measurement signal is measured by at least one electrode in contact with the user 1 1 .
  • the heart activity measurement signal may be acquired directly from said at least one electrode.
  • the heart activity measurement signal may be acquired wirelessly from the sensor device or from an internal sensor comprised in the user interface device 12, 14 and attached to the user 1 1 .
  • a phase of the heart activity measurement signal is monitored.
  • a phase component of the heart activity measurement signal may be extracted from the received heart activity measurement signal as described below, for example.
  • the phase of the heart activity measurement signal carries various information that may be used in improving the performance of the heart activity monitoring or even in determining other physiological parameters of the user 1 1 .
  • an action to be performed is determined on the basis of the phase of the heart activity measurement signal, and said action is carried out.
  • the action comprises is an output of an instruction to be provided to the user via a user interface.
  • the action comprises eliminating interfering signal components from further processing of the heart activity measurement signal.
  • the action comprises determining a physiological parameter of the user other than heart activity or heart rate.
  • the action comprises correcting measurement inaccuracies in the heart activity monitoring.
  • the action comprises selecting a measurement configuration.
  • the acquired heart activity measurement signal may be processed into a complex form by generating an in-phase (I) component and a quadrature (Q) component of the heart activity measurement signal, wherein a phase shift is provided between the I component and the Q component, as known in the art of signal processing.
  • the I and Q components of the heart activity measurement signal may then be processed with a wavelet transform 300.
  • a wavelet used as a basis for the wavelet transform may be selected according to design requirements by taking into account processing capabilities, for example.
  • the wavelet is designed to have a bandwidth which is equal to or higher than a bandwidth of the heart activity measurement signal.
  • the wavelet may be a Hanning wavelet, for example.
  • the wavelet transform may be approximated with a low pass filter designed according to the characteristics of the selected wavelet.
  • the phase of the heart activity measurement signal may be computed from the wavelet-transformed signal comprising the I and Q components by computing an argument of the signal (block 304).
  • the computation of the argument may utilize arctangent function, as known in the art of signal processing.
  • a phase component of the heart activity measurement signal is provided as an output of the argument computation in block 304.
  • amplitude or power characteristics of the heart activity measurement signal may be monitored by computing a second norm of the heart activity measurement signal.
  • the second norm also known as an Euclidean norm, may be computed by squaring the wavelet-transformed I and Q components of the heart activity measurement signal in block 302 and summing the squared I and Q components in block 306.
  • the amplitude characteristics may be used in computation of a heart rate or R-R intervals of the heart activity measurement signal.
  • An R-R interval refers to a time interval between consecutive R-wave components in the heart activity measurement signal.
  • FIG. 4 illustrates a phase diagram, wherein a QRS complex waveform has been illustrated in connection with phase shifts between 0 and 360 degrees.
  • phase shifts of 0 and 180 degrees result in an R wave having the highest amplitude.
  • the amplitude of the R wave decreases and the amplitude of an S wave increases.
  • the amplitude of the R wave decreases and the amplitude of a Q wave increases.
  • the absolute value of the amplitude of the R wave again increases, and the QRS complex waveform with the phase shift of 180 degrees is a mirror image of the QRS complex waveform with the phase shift of 0 degrees. It can be deduced that a phase shift of 0 and 180 degrees provide the strongest R wave.
  • Many heart activity detection procedures rely on detection of the R wave and, therefore, it is advantageous to provide a heart activity measurement signal having the strongest possible R wave in order to reduce the probability of not detecting the R wave or detecting the Q or S wave as the R wave. In this example, it would be beneficial to try to arrange the heart activity measurement signal to have a zero or 180 degree phase shift.
  • the phase diagram of Figure 4 illustrates an example case, and in real implementations the optimal phase shift may be different, depending on the design of the signal processing.
  • the optimal phase shift(s) may be determined by the parameters of the wavelet transform or the phase shift properties of the (low-pass) filter.
  • a person skilled in the art may easily find the analogy between the properties of the wavelet transform and, particularly, a phase shift of the wavelet used as a base for the transform, and the phase properties of the QRS complex waveform .
  • FIG. 5A illustrates the heart activity measurement signal in the form of a continuous ECG signal.
  • the heart activity measurement may be sampled and analogue-to-digital (A D) converted into a digital signal for signal processing.
  • Figure 5A illustrates the QRS complex waveforms used for determining a heart rate, for example.
  • Figure 5B illustrates a norm signal, e.g. the output of block 306.
  • the norm signal shows clear and distinct peaks at the same timings with the QRS complex waveforms.
  • the peaks may be used for computing R-R intervals and/or the heart rate, for example.
  • a detection threshold may be used to detect the peaks.
  • FIG. 5C shows the phase component of the heart activity signal, e.g. the output of block 304.
  • the phase component is a periodic signal.
  • the dominating frequency component is directly proportional to a respiratory rate of the user.
  • the respiratory rate is also known as a breathing frequency.
  • the respiratory rate may be determined from the phase component of the heart activity signal by determining a dominating frequency component in the phase component.
  • There are several state-of-the-art solutions for computing the dominating frequency component e.g. by detecting peaks in the phase component and an inverse of an average time interval between the peaks or by computing a fast Fourier transform (FFT) of the phase component and detecting a frequency component containing the highest amount of energy.
  • FFT fast Fourier transform
  • the periodicity of the phase component of the heart activity measurement signal is determined by determining the dominating frequency component.
  • the respiratory rate is determined from the periodicity, wherein the respiratory rate may equal the periodicity.
  • the respiratory rate may be stored in a memory unit of the exercise monitoring apparatus, it may be transmitted to another apparatus, and/or it may be output to the user 1 1 during the exercise (block 604).
  • the exercise monitoring apparatus is the sensor device 10 with no user interface
  • the sensor device 10 may transmit the respiratory rate to the user interface device 12, 14, and the user interface device 12, 14 may display or otherwise output the respiratory rate to the user 1 1 during the exercise.
  • the exercise monitoring apparatus is the user interface device 12, 14, the exercise monitoring apparatus may output the determined respiratory rate to the user via a user interface of the user interface device 12, 14 during the exercise.
  • the respiratory rate may be illustrated to the user 1 1 via a display screen.
  • FIG. 7A illustrates the heart activity measurement signal of Figure 5A, wherein strong interference signal components 700, 702 have been summed into the ECG signal in the electrode(s), for example.
  • strong interference may comprise motion artefacts resulting from the motion during the exercise (e.g. running), static electric components generated by the user 1 1 adjusting his/her shirt, etc.
  • the interference signal components 700, 702 also show in the norm signal ( Figure 7B) as additional peaks 704, 706 that degrade the analysis of the heart activity. It may provide false readings for the heart rate, for example.
  • Figure 7C illustrates the phase behaviour of the heart activity measurement signal comprising the interference signal components 700, 702.
  • the interference signal components 700, 702 create distinct peaks 708, 709 (a phase shift) to the phase component.
  • the phase of the ECG signal remains substantially constant over time (it has the periodic feature illustrated in Figure 5C), but the phase shifts caused by the interference signal components are typically strong and random in nature.
  • the phase variation caused by the interference signal components may be stronger or much stronger than the phase variation caused by the respiratory rate.
  • interference peaks 708, 709 in the phase component may be detected and signal components having the timing of the detected peaks of the phase component may be eliminated from the heart activity measurement signal (Figure 7A) and/or from the norm signal ( Figure 7B) such that they will not affect further analysis of the signal(s).
  • Block 800 the interference signal components 700, 702 in the heart activity measurement signal ( Figure 7A) are detected from the phase behaviour of the heart activity measurement signal ( Figure 7C).
  • Block 800 may comprise determining an average level of the phase of the heart activity measurement signal, determining a timing of phase samples of the heart activity measurement signal that deviate from the average level, and eliminating signal components of the heart activity measurement signal and/or the norm signal having said determined timing from further analysis (block 802).
  • a signal detection circuitry detecting the QRS complex waveforms from the norm signal may be configured to disregard signal components having the timing of the phase offsets 708, 709 caused by the interference signal components 700, 702.
  • the signal detection circuitry may eliminate or disregards any peaks having the timing of the determined interference signal components, e.g. it may eliminate the peaks 704, 706.
  • the average level of the phase component may first be determined. As described above, the phase of the ECG signal remains substantially constant, and the average level may be used to approximate the phase of the ECG signal. The average level may be computed by computing a mean or a median of the phase component within a determined sampling window. Therefore, the concept of average level represents an effective value of a plurality of successive phase values. As shown in Figure 7C, a tolerance zone may be provided around the average level.
  • the tolerance zone may be defined by a range or by an upper and a lower threshold. Any phase component falling outside the tolerance zone may be determined to be caused by an interference signal component, and the timing of such phase component samples may be stored for the elimination of the corresponding interference signal components in block 802.
  • the tolerance zone may be provided around the average level, because interference signal components typically cause a phase shift that may be a positive or negative offset (see phase shifts 708, 709 in Figure 7C).
  • the phase component is used to improve accuracy of estimation of a performance metric.
  • the phase component may be used to derive a correction factor that may be used to correct estimation inaccuracies in the performance metric.
  • the performance metric is computed from a heart rate variability derived from the heart activity measurement signal.
  • the performance metric characterizes user's physiological state before, during, or after training.
  • the performance metric characterizes an exertion level of the user.
  • the performance metric characterizes the status of the user's sympathetic and/or parasympathetic nervous system before, during or after training.
  • the performance metric characterizes the fitness level of the user.
  • the performance metric characterizes user's estimated time to recover from the training.
  • the performance metric characterizes the stress level of the user.
  • a signal shown in Figure 9A illustrates a deviation of R-R intervals of the heart activity measurement signal over time. As can be seen, an average level of the deviation rises at time instant T1 to a next level and stays there. This kind of behaviour may result from a change in the measurement configuration (e.g. a positioning of the electrodes) or in environmental conditions affecting the measurement of the ECG signal.
  • Figure 9B illustrates the phase component of the heart activity measurement signal and it has been discovered that the deviation in the phase component increases in proportion to the increase in the deviation of the R-R intervals. Additionally, Figure 9B shows a shift in the average level of the phase component, and the shift may be caused from the change in the measurement configuration, for example.
  • this embodiment utilizes the increase in the deviation (or variance or variability) of the phase component.
  • a deviation of the phase component of the heart activity measurement signal is computed.
  • the phase deviation may be a standard deviation of the phase within a determined observation window.
  • a correction factor is computed from the phase deviation.
  • the correction factor is used in computation of the performance metric based on the heart rate variability. Correlation between the deviation of the phase component and the deviation of the R-R intervals is found to be linear or at least approximately linear.
  • the correction factor scales and/or offsets the computed deviation of the R-R intervals, e.g. the computed deviation of the R-R intervals may be divided by the computed deviation of the phase component.
  • the computed deviation of the R-R intervals is multiplied by factor "a" and offset by a factor "b" as:
  • D R _ R Corrected D R _ R + b (1 )
  • D R-R represents the computed deviation of the R-R intervals
  • D R- R_corrected represents the deviation of the R-R intervals after the correction.
  • Factor "a” may be an inverse of the computed deviation of the phase component.
  • an observation interval used for estimating the performance metric is adjusted on the basis of the deviation of the phase component.
  • High deviation of the phase may increase errors in the detection of the QRS complexes (see description of Figure 4), and the observation interval may be adjusted such that a longer observation (or averaging) interval may be used for higher deviation of the phase component, and a shorter observation interval may be used for a lower deviation of the phase component.
  • a longer observation interval for averaging an effect of erroneous or missing detections of the QRS complexes on the performance metric reduces.
  • the phase of the QRS complex may affect the performance of any analysis of the heart rate measurement signal that utilizes the detection of the QRS complex waveform. Therefore, it may be advantageous to try to detect the phase of the QRS complex waveform and try to arrange it to be optimal for the detection of the QRS complex waveform.
  • Figure 1 1 illustrates an embodiment of block 202, wherein a phase of the QRS complex waveform is detected from the phase component of the heart activity measurement signal in block 1 100. In an embodiment, the phase of the QRS complex waveform is computed from the average level of the phase component.
  • the computation of the average level of the phase component may be carried out when computing the average level for the interference component elimination, as described above, or it may be carried out after the interference signal components have been identified and eliminated from the phase component as well. In the latter embodiment, accuracy of the estimation of the phase of the QRS complex waveform may be improved.
  • Figures 12 to 14 illustrate embodiments for adjusting the phase of the QRS complex waveform.
  • Figure 12 illustrates an embodiment of a measurement configuration used for measuring the ECG signals from the user's body, e.g. from the skin surface.
  • Figure 12 illustrates a strap comprising a plurality of electrodes 120, 122, 124, 126.
  • the number of electrodes may be at least three but, in general, the number of electrodes may be selected such that at least two different electrode subsets can be arranged to measure the ECG signal.
  • electrodes 120, 124 are used to provide a first measurement configuration
  • electrodes 122, 126 are used to realize a second measurement configuration. Due to the different positioning of the electrodes, each configuration is tuned to measure an ECG signal vector having a certain direction different from that to the vector direction(s) to which the other configuration(s) is/are tuned.
  • Figure 13 illustrates a process for determining an optimal measurement configuration by detecting the phase of the QRS complex waveforms acquired with different measurement configurations and by selecting the measurement configuration providing the most optimal phase of the QRS complex waveform.
  • the phase of the QRS complex waveform is computed from a heart activity measurement signal provided by the first measurement configuration in block 1300.
  • the phase of the QRS complex waveform is computed from a heart activity measurement signal provided by the second measurement configuration.
  • the phase of the QRS complex waveform is computed from one or more heart activity measurement signals provided by one or more other measurement configurations may be computed.
  • the sensor device comprising the electrodes 120 to 126 may comprise a switching mechanism to select the electrodes to be used and, thus, switch between the different measurement configurations.
  • the different measurement configurations may employ partially the same components in the measurement. Only the set of electrodes may change.
  • a measurement configuration providing the most optimal phase of the QRS complex is selected for use, and the heart rate detection and other analysis of the heart activity measurement signal (block 1306) is carried out by using the selected measurement configuration.
  • the measurement configuration selection procedure of Figure 13 may be repeated at determined intervals and/or upon detecting an event in the phase of the QRS complex waveform. For example, if the phase of the QRS complex waveform is detected to have shifted, the process of Figure 13 may be repeated. The process of Figure 13 may thus be used to correct the phase shift illustrated in connection with the embodiment of Figures 9A and 9B.
  • the user 1 1 could improve the performance of the heart activity measurements by adjusting the electrode(s).
  • the electrodes may need moisture in order to ensure a sufficient electric coupling between the electrodes and the user's 1 1 skin and, at the beginning of the exercise, the user might improve the electric coupling by moistening the electrodes.
  • adjusting the positioning of the electrodes with respect to the user's 1 1 body might improve the quality of the QRS complex waveform and performance of the detection of the QRS complex.
  • the exercise monitoring apparatus outputs, on the basis of analysing the phase component of the heart activity measurement signal, an instruction for the user to adjust at least one electrode measuring the heart activity data.
  • Figures 14 to 16 illustrate embodiments for determining what type of adjustment of the electrodes is needed, and the instruction is selected accordingly.
  • Figure 14 illustrates two exemplary phase components of heart activity measurement signals.
  • the average level of the phase component represents the phase of the QRS complex waveform in the detection circuitry. Keeping the average level of the phase component within a determined range around at least one of the optimal phases of the QRS complex waveform causes efficient performance in the QRS complex detection. The determined range is called "optimal range" in Figure 14.
  • the phase component 1400 stays within the optimal range, so no adjustment is needed.
  • phase component 1402 is not within the optimal range
  • the exercise monitoring apparatus detecting that the phase component 1402 is not within the optimal range may output the instruction for the user to change the positioning of the electrodes in order to change the direction of the ECG signal vector and change the phase of the QRS complex waveform.
  • Figure 15 illustrates a flow diagram of this process according to an embodiment of the invention.
  • Figure 15 illustrates an embodiment of blocks 202 and 204.
  • the exercise monitoring apparatus computes the phase of the QRS complex waveform from the phase behaviour of the heart activity measurement signal in block 1 100, as described in connection with Figure 1 1 .
  • the phase of the QRS complex waveform may be computed by determining the average level of the phase component within an observation interval. Then, the phase of the QRS complex wave form may be compared with the optimal range determined by at least one phase threshold. In block 1500 it is determined whether or not the phase of the QRS complex waveform falls within the optimal range. If the phase of the QRS complex waveform is within the optimal range, the monitoring of the phase behaviour is continued and the process may return to block 1 100.
  • the process proceeds to block 1502 in which the instruction to adjust the positioning of the electrodes is output to the user via the user interface.
  • the output instruction may specify that the user is instructed to move the electrodes laterally with respect to the user's body, e.g. to the left or to the right.
  • the monitoring of the phase of the QRS complex waveform may be continued in block 1 100.
  • Motion artefacts caused by the user's 1 1 motion during the exercise may interfere with the measurements.
  • a typical interference model is caused by the motion in connection with running, wherein the signal detection circuitry attempting to detect the QRS complexes ends up detecting motion artefacts caused by stride impacts, and the heart rate measurement is distorted to show stride rate.
  • the impact in connection with each stride may cause motion of the electrodes with respect to the user's body or motion of clothes the user is wearing, and the result may be a high-level electric interference component induced to the electrodes.
  • Figure 16 illustrates an embodiment of a process for detecting the motion artefacts and instructing the user to adjust the electrodes to reduce the motion artefacts.
  • the exercise monitoring apparatus computes the deviation in the phase component of the heart activity measurement signal in block 1600.
  • the phase deviation is computed as:
  • Pd(n) FIR * abs(PP(n)) (2)
  • FIR represents a low-pass filter
  • * " represents a convolution operation
  • abs represents absolute value
  • PP represent a difference between consecutive phase samples (P(n)-P(n-1 )).
  • the low-pass filter serves as an averaging function. Since the motion artefacts are typically strong signal components and have random phase, they dominate over the ECG signal and increase the phase deviation of the phase component. Let us remind that the average level of the phase component stays relatively constant.
  • the threshold may be selected sufficiently high such that the deviation caused by the periodicity of the phase component described in connection with Figure 5C does not cause the threshold being exceeded.
  • any other metric proportional to the deviation may be used, e.g. the variance. If the deviation is below the threshold (or within an allowed range), the monitoring of the phase deviation is continued in block 1600. On the other hand, if the phase deviation is above the threshold (or outside the allowed range), the process proceeds to block 1604 in which an instruction is output to instruct the user to moisten the electrode(s). Moistening improves the electric contact and reduces the motion artefacts. This instruction may also be output via the user interface of the exercise monitoring apparatus or through a user interface of another apparatus, e.g. through the user interface device 12, 14 when the exercise monitoring apparatus is the sensor device 10.
  • Figure 17 illustrates a block diagram of the exercise monitoring apparatus according to an embodiment of the invention.
  • the exercise monitoring apparatus may be sensor device 10, the user interface device 12, 14, or any other apparatus configured to monitor the heart activity measurement signals measured from the user's body during the physical exercise.
  • the apparatus comprises a least one processor 60 and at least one memory 70 storing a computer program code 76.
  • the computer program code 76 configures the processor to carry out embodiments of the invention, e.g. any one of the embodiments described above.
  • the memory 70 may further store a training database 74 in which any parameters and performance metrics measured and/or computed during the exercise may be stored.
  • the memory 70 may further store any thresholds 72 and/or any other parameters or criteria used in the embodiments described above.
  • the apparatus may further comprise a communication circuitry 52 providing the apparatus with communication capability.
  • the communication circuitry may support any wired or wireless communication technique, e.g. Bluetooth, Bluetooth Low energy, IEEE 802.15, IEEE 802.1 1 , W.I.N. D, ANT by Dynastream, or any other radio or induction-based communication technique.
  • the apparatus may further comprise at least one sensor 50 configured to measure the heart activity of the user 1 1 .
  • the sensor(s) may comprise the above-described electrodes and appropriate circuitry to process the heart activity measurement signals.
  • the apparatus may further comprise the user interface 54 for user interaction.
  • the user interface 54 may comprise an output device and an input device.
  • the output device may comprise a display unit (e.g. a liquid crystal display) and the input device may comprise one or more buttons or keys or a touch-sensitive display.
  • the processor 60 may comprise one or more sub-circuitries 62 to
  • the sub- circuitries 62 to 69 may be physical circuitries in the processor 60, or they may be realized by separate computer program modules, and the at least partially the same physical circuitries of the processor may carry out the operations of different modules 62 to 69.
  • the processor 60 may receive the heart activity measurement signal from the at least one sensor 50 or through the communication circuitry 52.
  • the processor may comprise a phase extraction circuitry 62 configured to extract the phase component from the heart activity measurement signal and output the extracted phase component for further analysis.
  • the processor 60 may further comprise a QRS detection circuitry 64 configured to detect the QRS complex waveform from the heart activity measurement signal. The operation of the QRS detection circuitry 64 may be based on detecting the R wave, for example.
  • the QRS detection circuitry 64 or the processor 60 may then compute various performance metrics from the detected QRS waveforms, e.g. the heart rate, heart rate variability, energy consumption, and/or exertion level.
  • the processor 60 may comprise a QRS phase detection circuitry 66 configured to monitor the phase of the QRS complex waveform from the phase component received from the phase extraction circuitry 62, as described above in connection with Figures 1 1 to 15.
  • the QRS phase detection circuitry 66 may be configured to carry out at least some of the actions on the basis of the detected phase of the QRS complex waveform, as described above.
  • the QRS phase detection circuitry may select an optimal measurement configuration (an optimal set of electrodes to provide the heart activity measurement signal) or control the user interface 54 to output an instruction for the user to adjust the positioning of the electrodes, e.g. to adjust the strap comprising the electrodes.
  • the processor 60 may comprise an interference detection circuitry 67 configured to determine the presence of the interference signal components in the heart activity measurement signal and control the elimination of the interference signal components from the analysis of the heart activity measurement signal.
  • the interference detection circuitry may carry out the process described above in connection with Figures 7A to 8, and the interference detection circuitry may output the detected timings of the interference signal components to the QRS detection circuitry 64 such that the QRS detection circuitry 64 may eliminate any signal components having the timing received from the interference detection circuitry 67.
  • the interference detection circuitry may receive the heart activity measurement signal before it is input to the QRS detection circuitry 64, remove the interference signal components from the heart activity measurement signal, and output the interference-suppressed heart activity measurement signal to the QRS detection circuitry 64.
  • the processor 60 may further comprise a respiratory rate detection circuitry 68 configured to determine the user's respiratory rate from the periodicity of the phase component, as described above in connection with Figures 5 and 6.
  • the processor may further comprise a phase deviation detection circuitry 69 configured to monitor the phase deviation of the phase component.
  • the phase deviation detection circuitry may carry out any one of the embodiments described above in connection with Figures 9A, 9B, 10, and 16, and carry out a corresponding action.
  • the phase deviation detection circuitry 69 may compute the correction factor for use in computation of the performance metric or the heart rate variability in the QRS detection circuitry 64, or the phase deviation detection circuitry 69 may output an instruction for the user to moisten the electrodes.
  • circuitry refers to all of the following: (a) hardware-only circuit implementations such as implementations in only analog and/or digital circuitry; (b) combinations of circuits and software and/or firmware, such as (as applicable): (i) a combination of processor(s) or processor cores; or (ii) portions of processor(s)/software including digital signal processor(s), software, and at least one memory that work together to cause an apparatus to perform specific functions; and (c) circuits, such as a microprocessor(s) or a portion of a microprocessor(s), that require software or firmware for operation, even if the software or firmware is not physically present.
  • circuitry would also cover an implementation of merely a processor (or multiple processors) or portion of a processor, e.g. one core of a multi-core processor, and its (or their) accompanying software and/or firmware.
  • circuitry would also cover, for example and if applicable to the particular element, a baseband integrated circuit, an application-specific integrated circuit (ASIC), and/or a field-programmable grid array (FPGA) circuit for the apparatus according to an embodiment of the invention.
  • ASIC application-specific integrated circuit
  • FPGA field-programmable grid array
  • the processes or methods described in Figures 4 to 8 may also be carried out in the form of a computer process defined by a computer program.
  • the computer program may be in source code form, object code form, or in some intermediate form, and it may be stored in some sort of carrier, which may be any entity or device capable of carrying the program.
  • Such carriers include transitory and/or non-transitory computer media, e.g. a record medium, computer memory, read-only memory, electrical carrier signal, telecommunications signal, and software distribution package.
  • the computer program may be executed in a single electronic digital processing unit or it may be distributed amongst a number of processing units.
  • the present invention is applicable to exercise monitoring systems described above but also to other suitable exercise monitoring systems.
  • the technology may evolve over time and the development may require extra changes to the described embodiments. Therefore, all words and expressions should be interpreted broadly and they are intended to illustrate, not to restrict, the embodiments. It will be obvious to a person skilled in the art that, as technology advances, the inventive concept can be implemented in various ways.
  • the invention and its embodiments are not limited to the examples described above but may vary within the scope of the claims.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Cardiology (AREA)
  • Signal Processing (AREA)
  • Physiology (AREA)
  • Artificial Intelligence (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Psychiatry (AREA)
  • Pulmonology (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)

Abstract

This document discloses a method, apparatus, and computer program for monitoring user's heart activity during a physical exercise. A heart activity measurement signal representing the user's heart activity is acquired and a phase component of the heart activity measurement signal is monitored. On the basis of said monitoring of the phase component, one or more actions are carried out.

Description

Improvements in Heart Activity Monitoring during Physical Exercise
Field
The invention relates to the field of training devices and, particularly to training devices monitoring heart activity of a user during a physical exercise.
Background
Personal training devices monitoring heart activity of a user have been in commercial use. Such training devices typically comprise electrodes that are placed into contact with the user's skin, and they measure a heart activity signal such as an electrocardiogram (ECG) signal non-invasively from the user's skin by using electric sensors, for example.
Brief description
The invention is defined by the independent claims.
Embodiments of the invention are defined in the dependent claims.
List of drawings
Embodiments of the present invention are described below, by way of example only, with reference to the accompanying drawings, in which
Figure 1 illustrates an exercise monitoring system according to an embodiment of the invention;
Figure 2 illustrates a flow diagram of a process for monitoring the phase of a heart activity measurement signal measured from the user's body during a physical exercise;
Figure 3 illustrates a circuitry for extracting a phase component from the heart activity measurement signal according to an embodiment of the invention;
Figure 4 illustrates a phase diagram and phases of a QRS complex waveform;
Figures 5A to 5C illustrate the heart activity measurement signal and its components;
Figure 6 illustrates a flow diagram of a process for determining a physiological parameter from the phase component of the heart activity measurement signal according to an embodiment of the invention; Figures 7A to 7C illustrate the heart activity measurement signal and its components with an interference signal component;
Figure 8 illustrates a flow diagram of a process for detecting the interference signal components from the phase component of the heart activity measurement signal according to an embodiment of the invention;
Figures 9A and 9B illustrate correlation between deviation of R-R intervals and phase behaviour of the heart activity measurement signal;
Figure 10 illustrates a flow diagram of a process for determining a correction factor for computation of a performance metric from the phase component of the heart activity measurement signal according to an embodiment of the invention;
Figure 1 1 illustrates a flow diagram of a process for computing a phase of a QRS complex waveform from the phase component of the heart activity measurement signal according to an embodiment of the invention;
Figure 12 illustrates an embodiment of a measurement configuration for measuring the heart activity of the user;
Figure 13 illustrates a flow diagram of a process for determining an optimal measurement configuration from the phase component of the heart activity measurement signal according to an embodiment of the invention;
Figure 14 illustrates phase behaviour of heart activity measurement signals;
Figure 15 illustrates a flow diagram of a process for instructing the user to adjust the measurement configuration on the basis of analysing the phase component of the heart activity measurement signal according to an embodiment of the invention;
Figure 16 illustrates a flow diagram of a process for monitoring deviation of the phase component of the heart activity measurement signal and instructing the user accordingly according to an embodiment of the invention; and
Figure 17 illustrates a block diagram of an exercise monitoring apparatus according to an embodiment of the invention.
Description of embodiments
The following embodiments are exemplary. Although the specification may refer to "an", "one", or "some" embodiment(s) in several locations, this does not necessarily mean that each such reference is to the same embodiment(s), or that the feature only applies to a single embodiment. Single features of different embodiments may also be combined to provide other embodiments. Furthermore, words "comprising" and "including" should be understood as not limiting the described embodiments to consist of only those features that have been mentioned and such embodiments may contain also features/structures that have not been specifically mentioned.
Figure 1 illustrates an embodiment of a personal training system comprising a sensor device 10 configured to measure heart activity signals from a user's 1 1 body. The sensor device 10 may comprise one or a plurality of skin electrodes coupled to the user's 1 1 skin. The sensor device 10 may be based on detection of an electrocardiogram (ECG) signal from the user's 1 1 skin. The heart activity measurement signals measured from the user's body may comprise the ECG signal being detected and, possibly, noise and interference components.
The sensor device 10 may further comprise a wireless communication circuitry configured to transmit measured heart activity measurement signals to another device, e.g. a user interface device 12, 14. The user interface device 12, 14 may be configured to process the received heart activity measurement signals and to illustrate training processed from the heart activity measurement signals to the user 1 1 via a display unit, for example.
In an embodiment, the user interface unit device a wrist device 12. In an embodiment, the user interface device is a portable computer 14 such as a mobile phone or a tablet computer.
Embodiments of the invention relate to monitoring properties of the heart activity measurement signals measured from the user's 1 1 skin. The embodiments may be carried out in any one of the above-described devices 10, 12, 14 or in any other device acquiring the heart activity measurement signals. The devices 10, 12, 14 may collectively be referred to as exercise monitoring apparatuses.
Figure 2 illustrates a method for processing a heart activity measurement signal in such an exercise monitoring apparatus. Referring to Figure 2, the heart activity measurement signal of a user 1 1 is acquired during a physical exercise performed by the user in block 200. The heart activity measurement signal is measured by at least one electrode in contact with the user 1 1 . In the embodiment where the method is carried out in the sensor device 10, the heart activity measurement signal may be acquired directly from said at least one electrode. In the embodiment where the method is carried out in the user interface device 12, 14, the heart activity measurement signal may be acquired wirelessly from the sensor device or from an internal sensor comprised in the user interface device 12, 14 and attached to the user 1 1 .
In block 202, a phase of the heart activity measurement signal is monitored. A phase component of the heart activity measurement signal may be extracted from the received heart activity measurement signal as described below, for example. As described in this document, the phase of the heart activity measurement signal carries various information that may be used in improving the performance of the heart activity monitoring or even in determining other physiological parameters of the user 1 1 . In block 204, an action to be performed is determined on the basis of the phase of the heart activity measurement signal, and said action is carried out.
In an embodiment, the action comprises is an output of an instruction to be provided to the user via a user interface.
In an embodiment, the action comprises eliminating interfering signal components from further processing of the heart activity measurement signal.
In an embodiment, the action comprises determining a physiological parameter of the user other than heart activity or heart rate.
In an embodiment, the action comprises correcting measurement inaccuracies in the heart activity monitoring.
In an embodiment, the action comprises selecting a measurement configuration.
Before describing the various embodiments of using the phase of the heart activity measurement signal, let us consider an embodiment of extracting the phase from the acquired heart activity measurement signal with reference to Figure 3. The acquired heart activity measurement signal may be processed into a complex form by generating an in-phase (I) component and a quadrature (Q) component of the heart activity measurement signal, wherein a phase shift is provided between the I component and the Q component, as known in the art of signal processing. The I and Q components of the heart activity measurement signal may then be processed with a wavelet transform 300. A wavelet used as a basis for the wavelet transform may be selected according to design requirements by taking into account processing capabilities, for example. In an embodiment, the wavelet is designed to have a bandwidth which is equal to or higher than a bandwidth of the heart activity measurement signal. The wavelet may be a Hanning wavelet, for example. In practical implementations, the wavelet transform may be approximated with a low pass filter designed according to the characteristics of the selected wavelet.
The phase of the heart activity measurement signal may be computed from the wavelet-transformed signal comprising the I and Q components by computing an argument of the signal (block 304). The computation of the argument may utilize arctangent function, as known in the art of signal processing. As an output of the argument computation in block 304, a phase component of the heart activity measurement signal is provided.
Similarly, amplitude or power characteristics of the heart activity measurement signal may be monitored by computing a second norm of the heart activity measurement signal. The second norm, also known as an Euclidean norm, may be computed by squaring the wavelet-transformed I and Q components of the heart activity measurement signal in block 302 and summing the squared I and Q components in block 306. The amplitude characteristics may be used in computation of a heart rate or R-R intervals of the heart activity measurement signal. An R-R interval refers to a time interval between consecutive R-wave components in the heart activity measurement signal.
Let us now consider how the phase shift of the heart activity measurement signal affects a QRS complex waveform comprised in the heart activity measurement signal with reference to Figure 4. Figure 4 illustrates a phase diagram, wherein a QRS complex waveform has been illustrated in connection with phase shifts between 0 and 360 degrees. As can be seen in Figure 4, phase shifts of 0 and 180 degrees result in an R wave having the highest amplitude. As the phase shifts from the 0 degrees towards 90 degrees, the amplitude of the R wave decreases and the amplitude of an S wave increases. Similarly, when the phase shifts from the 0 degrees towards 270 degrees, the amplitude of the R wave decreases and the amplitude of a Q wave increases. When closing the 180 degrees, the absolute value of the amplitude of the R wave again increases, and the QRS complex waveform with the phase shift of 180 degrees is a mirror image of the QRS complex waveform with the phase shift of 0 degrees. It can be deduced that a phase shift of 0 and 180 degrees provide the strongest R wave. Many heart activity detection procedures rely on detection of the R wave and, therefore, it is advantageous to provide a heart activity measurement signal having the strongest possible R wave in order to reduce the probability of not detecting the R wave or detecting the Q or S wave as the R wave. In this example, it would be beneficial to try to arrange the heart activity measurement signal to have a zero or 180 degree phase shift.
It should be appreciated that the phase diagram of Figure 4 illustrates an example case, and in real implementations the optimal phase shift may be different, depending on the design of the signal processing. Referring to the embodiment of Figure 3, the optimal phase shift(s) may be determined by the parameters of the wavelet transform or the phase shift properties of the (low-pass) filter. A person skilled in the art may easily find the analogy between the properties of the wavelet transform and, particularly, a phase shift of the wavelet used as a base for the transform, and the phase properties of the QRS complex waveform .
Let us now consider various embodiments for employing the phase component of the heart activity measurement signal with reference to Figures 5A to 15. First, let us consider with reference to Figures 5A to 6 an embodiment determining a physiological parameter of the user from the phase of the heart activity measurement signal. Figure 5A illustrates the heart activity measurement signal in the form of a continuous ECG signal. In real implementations, the heart activity measurement may be sampled and analogue-to-digital (A D) converted into a digital signal for signal processing. Figure 5A illustrates the QRS complex waveforms used for determining a heart rate, for example. Figure 5B illustrates a norm signal, e.g. the output of block 306. As shown in Figure 5B, the norm signal shows clear and distinct peaks at the same timings with the QRS complex waveforms. The peaks may be used for computing R-R intervals and/or the heart rate, for example. A detection threshold may be used to detect the peaks.
Figure 5C shows the phase component of the heart activity signal, e.g. the output of block 304. It can be seen that the phase component is a periodic signal. The dominating frequency component is directly proportional to a respiratory rate of the user. The respiratory rate is also known as a breathing frequency. The respiratory rate may be determined from the phase component of the heart activity signal by determining a dominating frequency component in the phase component. There are several state-of-the-art solutions for computing the dominating frequency component, e.g. by detecting peaks in the phase component and an inverse of an average time interval between the peaks or by computing a fast Fourier transform (FFT) of the phase component and detecting a frequency component containing the highest amount of energy.
Referring to Figure 6, let us consider an embodiment of a process for determining the respiratory rate in the exercise monitoring apparatus. In block 600, the periodicity of the phase component of the heart activity measurement signal is determined by determining the dominating frequency component. In block 602, the respiratory rate is determined from the periodicity, wherein the respiratory rate may equal the periodicity. The respiratory rate may be stored in a memory unit of the exercise monitoring apparatus, it may be transmitted to another apparatus, and/or it may be output to the user 1 1 during the exercise (block 604). In the embodiment where the exercise monitoring apparatus is the sensor device 10 with no user interface, the sensor device 10 may transmit the respiratory rate to the user interface device 12, 14, and the user interface device 12, 14 may display or otherwise output the respiratory rate to the user 1 1 during the exercise. In the embodiment where the exercise monitoring apparatus is the user interface device 12, 14, the exercise monitoring apparatus may output the determined respiratory rate to the user via a user interface of the user interface device 12, 14 during the exercise. The respiratory rate may be illustrated to the user 1 1 via a display screen.
Next, let us describe an embodiment for using the phase component for eliminating interference components from the heart activity measurement signal and preventing them from affecting the analysis of the heart activity. Figure 7A illustrates the heart activity measurement signal of Figure 5A, wherein strong interference signal components 700, 702 have been summed into the ECG signal in the electrode(s), for example. Such strong interference may comprise motion artefacts resulting from the motion during the exercise (e.g. running), static electric components generated by the user 1 1 adjusting his/her shirt, etc. The interference signal components 700, 702 also show in the norm signal (Figure 7B) as additional peaks 704, 706 that degrade the analysis of the heart activity. It may provide false readings for the heart rate, for example. It may be difficult to detect the interference signal components from the norm signal, because they show as very similar peaks than the peaks caused by the ECG signal that is being detected. Extraction of the interference signal components from the heart activity measurement signal (Figure 7A) may be even more difficult, because the interference signals are typically more mixed with the ECG signal and noise.
Figure 7C illustrates the phase behaviour of the heart activity measurement signal comprising the interference signal components 700, 702. As can be seen from Figure 7C, the interference signal components 700, 702 create distinct peaks 708, 709 (a phase shift) to the phase component. The phase of the ECG signal remains substantially constant over time (it has the periodic feature illustrated in Figure 5C), but the phase shifts caused by the interference signal components are typically strong and random in nature. The phase variation caused by the interference signal components may be stronger or much stronger than the phase variation caused by the respiratory rate. These interference peaks 708, 709 in the phase component may be detected and signal components having the timing of the detected peaks of the phase component may be eliminated from the heart activity measurement signal (Figure 7A) and/or from the norm signal (Figure 7B) such that they will not affect further analysis of the signal(s).
Let us now consider an embodiment for eliminating or reducing interference signal components with reference to Figure 8. In block 800, the interference signal components 700, 702 in the heart activity measurement signal (Figure 7A) are detected from the phase behaviour of the heart activity measurement signal (Figure 7C). Block 800 may comprise determining an average level of the phase of the heart activity measurement signal, determining a timing of phase samples of the heart activity measurement signal that deviate from the average level, and eliminating signal components of the heart activity measurement signal and/or the norm signal having said determined timing from further analysis (block 802). For example, a signal detection circuitry detecting the QRS complex waveforms from the norm signal may be configured to disregard signal components having the timing of the phase offsets 708, 709 caused by the interference signal components 700, 702. If the detection of the QRS complex waveforms is based on peak detection, the signal detection circuitry may eliminate or disregards any peaks having the timing of the determined interference signal components, e.g. it may eliminate the peaks 704, 706. In the detection of the tinning of the interference signal components from the phase component of Figure 7C, the average level of the phase component may first be determined. As described above, the phase of the ECG signal remains substantially constant, and the average level may be used to approximate the phase of the ECG signal. The average level may be computed by computing a mean or a median of the phase component within a determined sampling window. Therefore, the concept of average level represents an effective value of a plurality of successive phase values. As shown in Figure 7C, a tolerance zone may be provided around the average level. The tolerance zone may be defined by a range or by an upper and a lower threshold. Any phase component falling outside the tolerance zone may be determined to be caused by an interference signal component, and the timing of such phase component samples may be stored for the elimination of the corresponding interference signal components in block 802. The tolerance zone may be provided around the average level, because interference signal components typically cause a phase shift that may be a positive or negative offset (see phase shifts 708, 709 in Figure 7C).
Let us next describe an embodiment where the phase component is used to improve accuracy of estimation of a performance metric. In particular, the phase component may be used to derive a correction factor that may be used to correct estimation inaccuracies in the performance metric. In an embodiment, the performance metric is computed from a heart rate variability derived from the heart activity measurement signal.
In an embodiment, the performance metric characterizes user's physiological state before, during, or after training.
In an embodiment, the performance metric characterizes an exertion level of the user.
In an embodiment, the performance metric characterizes the status of the user's sympathetic and/or parasympathetic nervous system before, during or after training.
In an embodiment, the performance metric characterizes the fitness level of the user.
In an embodiment, the performance metric characterizes user's estimated time to recover from the training.
In an embodiment, the performance metric characterizes the stress level of the user. A signal shown in Figure 9A illustrates a deviation of R-R intervals of the heart activity measurement signal over time. As can be seen, an average level of the deviation rises at time instant T1 to a next level and stays there. This kind of behaviour may result from a change in the measurement configuration (e.g. a positioning of the electrodes) or in environmental conditions affecting the measurement of the ECG signal. Figure 9B illustrates the phase component of the heart activity measurement signal and it has been discovered that the deviation in the phase component increases in proportion to the increase in the deviation of the R-R intervals. Additionally, Figure 9B shows a shift in the average level of the phase component, and the shift may be caused from the change in the measurement configuration, for example. However, this embodiment utilizes the increase in the deviation (or variance or variability) of the phase component. Let us describe a process for using the phase component to improve the accuracy of the performance metric with reference to Figure 10. In block 1000, a deviation of the phase component of the heart activity measurement signal is computed. The phase deviation may be a standard deviation of the phase within a determined observation window. In block 1002, a correction factor is computed from the phase deviation. In block 1004, the correction factor is used in computation of the performance metric based on the heart rate variability. Correlation between the deviation of the phase component and the deviation of the R-R intervals is found to be linear or at least approximately linear.
In an embodiment where the deviation of the R-R intervals is monitored, the correction factor scales and/or offsets the computed deviation of the R-R intervals, e.g. the computed deviation of the R-R intervals may be divided by the computed deviation of the phase component. In another embodiment, the computed deviation of the R-R intervals is multiplied by factor "a" and offset by a factor "b" as:
DR_R Corrected = DR_R + b (1 ) where DR-R represents the computed deviation of the R-R intervals, and DR- R_corrected represents the deviation of the R-R intervals after the correction. Factor "a" may be an inverse of the computed deviation of the phase component.
In an embodiment, an observation interval used for estimating the performance metric is adjusted on the basis of the deviation of the phase component. High deviation of the phase may increase errors in the detection of the QRS complexes (see description of Figure 4), and the observation interval may be adjusted such that a longer observation (or averaging) interval may be used for higher deviation of the phase component, and a shorter observation interval may be used for a lower deviation of the phase component. By using a longer observation interval for averaging, an effect of erroneous or missing detections of the QRS complexes on the performance metric reduces.
As described above in connection with Figure 4, the phase of the QRS complex may affect the performance of any analysis of the heart rate measurement signal that utilizes the detection of the QRS complex waveform. Therefore, it may be advantageous to try to detect the phase of the QRS complex waveform and try to arrange it to be optimal for the detection of the QRS complex waveform. Figure 1 1 illustrates an embodiment of block 202, wherein a phase of the QRS complex waveform is detected from the phase component of the heart activity measurement signal in block 1 100. In an embodiment, the phase of the QRS complex waveform is computed from the average level of the phase component. The computation of the average level of the phase component may be carried out when computing the average level for the interference component elimination, as described above, or it may be carried out after the interference signal components have been identified and eliminated from the phase component as well. In the latter embodiment, accuracy of the estimation of the phase of the QRS complex waveform may be improved. Figures 12 to 14 illustrate embodiments for adjusting the phase of the QRS complex waveform.
As a background for the embodiments of Figures 13 and 14, it is known that vectors of an ECG signal of different users may have different directions which may affect the measurement of the ECG signal. A given positioning of the electrode(s) may be optimal for one user but sub-optimal for another user because of different directions of their personal ECG vectors. As a consequence, the positioning of the electrodes may have an effect on the phase of the QRS complex waveform (see Figure 4), and wrong positioning may cause errors in detection of the QRS complex waveforms.
Figure 12 illustrates an embodiment of a measurement configuration used for measuring the ECG signals from the user's body, e.g. from the skin surface. Figure 12 illustrates a strap comprising a plurality of electrodes 120, 122, 124, 126. The number of electrodes may be at least three but, in general, the number of electrodes may be selected such that at least two different electrode subsets can be arranged to measure the ECG signal. In this example, electrodes 120, 124 are used to provide a first measurement configuration, and electrodes 122, 126 are used to realize a second measurement configuration. Due to the different positioning of the electrodes, each configuration is tuned to measure an ECG signal vector having a certain direction different from that to the vector direction(s) to which the other configuration(s) is/are tuned.
Figure 13 illustrates a process for determining an optimal measurement configuration by detecting the phase of the QRS complex waveforms acquired with different measurement configurations and by selecting the measurement configuration providing the most optimal phase of the QRS complex waveform. Referring to Figure 13, the phase of the QRS complex waveform is computed from a heart activity measurement signal provided by the first measurement configuration in block 1300. In block 1302, the phase of the QRS complex waveform is computed from a heart activity measurement signal provided by the second measurement configuration. Similarly, the phase of the QRS complex waveform is computed from one or more heart activity measurement signals provided by one or more other measurement configurations may be computed. The sensor device comprising the electrodes 120 to 126 may comprise a switching mechanism to select the electrodes to be used and, thus, switch between the different measurement configurations. In this manner, the different measurement configurations may employ partially the same components in the measurement. Only the set of electrodes may change. In block 1304, a measurement configuration providing the most optimal phase of the QRS complex is selected for use, and the heart rate detection and other analysis of the heart activity measurement signal (block 1306) is carried out by using the selected measurement configuration. The measurement configuration selection procedure of Figure 13 may be repeated at determined intervals and/or upon detecting an event in the phase of the QRS complex waveform. For example, if the phase of the QRS complex waveform is detected to have shifted, the process of Figure 13 may be repeated. The process of Figure 13 may thus be used to correct the phase shift illustrated in connection with the embodiment of Figures 9A and 9B.
In some scenarios, the user 1 1 could improve the performance of the heart activity measurements by adjusting the electrode(s). For example, the electrodes may need moisture in order to ensure a sufficient electric coupling between the electrodes and the user's 1 1 skin and, at the beginning of the exercise, the user might improve the electric coupling by moistening the electrodes. According to another aspect referring to the direction of the ECG signal vector that may be unique to user, adjusting the positioning of the electrodes with respect to the user's 1 1 body might improve the quality of the QRS complex waveform and performance of the detection of the QRS complex.
In an embodiment, the exercise monitoring apparatus outputs, on the basis of analysing the phase component of the heart activity measurement signal, an instruction for the user to adjust at least one electrode measuring the heart activity data. Figures 14 to 16 illustrate embodiments for determining what type of adjustment of the electrodes is needed, and the instruction is selected accordingly. Figure 14 illustrates two exemplary phase components of heart activity measurement signals. As described above in connection with Figures 12 and 13, the average level of the phase component represents the phase of the QRS complex waveform in the detection circuitry. Keeping the average level of the phase component within a determined range around at least one of the optimal phases of the QRS complex waveform causes efficient performance in the QRS complex detection. The determined range is called "optimal range" in Figure 14. The phase component 1400 stays within the optimal range, so no adjustment is needed. However, the phase component 1402 is not within the optimal range, and the exercise monitoring apparatus detecting that the phase component 1402 is not within the optimal range may output the instruction for the user to change the positioning of the electrodes in order to change the direction of the ECG signal vector and change the phase of the QRS complex waveform. Figure 15 illustrates a flow diagram of this process according to an embodiment of the invention. Figure 15 illustrates an embodiment of blocks 202 and 204.
Referring to Figure 15, the exercise monitoring apparatus computes the phase of the QRS complex waveform from the phase behaviour of the heart activity measurement signal in block 1 100, as described in connection with Figure 1 1 . The phase of the QRS complex waveform may be computed by determining the average level of the phase component within an observation interval. Then, the phase of the QRS complex wave form may be compared with the optimal range determined by at least one phase threshold. In block 1500 it is determined whether or not the phase of the QRS complex waveform falls within the optimal range. If the phase of the QRS complex waveform is within the optimal range, the monitoring of the phase behaviour is continued and the process may return to block 1 100. On the other hand, if the phase of the QRS complex waveform is outside the optimal range, the process proceeds to block 1502 in which the instruction to adjust the positioning of the electrodes is output to the user via the user interface. Typically, a lateral repositioning may cause a sufficient shift in the phase of the QRS complex waveform, so the output instruction may specify that the user is instructed to move the electrodes laterally with respect to the user's body, e.g. to the left or to the right. Thereafter, the monitoring of the phase of the QRS complex waveform may be continued in block 1 100.
Motion artefacts caused by the user's 1 1 motion during the exercise may interfere with the measurements. A typical interference model is caused by the motion in connection with running, wherein the signal detection circuitry attempting to detect the QRS complexes ends up detecting motion artefacts caused by stride impacts, and the heart rate measurement is distorted to show stride rate. The impact in connection with each stride may cause motion of the electrodes with respect to the user's body or motion of clothes the user is wearing, and the result may be a high-level electric interference component induced to the electrodes. The appearance of the motion artefacts depends on the user; some users are prone to create the motion artefacts, particularly at the beginning of the exercise when the contact between the electrodes and the user's skin has not been improved by the natural moisture created by the human bod during the exercise. Figure 16 illustrates an embodiment of a process for detecting the motion artefacts and instructing the user to adjust the electrodes to reduce the motion artefacts. Referring to Figure 16, the exercise monitoring apparatus computes the deviation in the phase component of the heart activity measurement signal in block 1600. In an embodiment, the phase deviation is computed as:
Pd(n) = FIR * abs(PP(n)) (2) where FIR represents a low-pass filter, "*" represents a convolution operation, abs represents absolute value, and PP represent a difference between consecutive phase samples (P(n)-P(n-1 )). The low-pass filter serves as an averaging function. Since the motion artefacts are typically strong signal components and have random phase, they dominate over the ECG signal and increase the phase deviation of the phase component. Let us remind that the average level of the phase component stays relatively constant. In block 1602, it is determined whether or not the deviation is above a threshold. The threshold may be selected sufficiently high such that the deviation caused by the periodicity of the phase component described in connection with Figure 5C does not cause the threshold being exceeded. Equally, any other metric proportional to the deviation may be used, e.g. the variance. If the deviation is below the threshold (or within an allowed range), the monitoring of the phase deviation is continued in block 1600. On the other hand, if the phase deviation is above the threshold (or outside the allowed range), the process proceeds to block 1604 in which an instruction is output to instruct the user to moisten the electrode(s). Moistening improves the electric contact and reduces the motion artefacts. This instruction may also be output via the user interface of the exercise monitoring apparatus or through a user interface of another apparatus, e.g. through the user interface device 12, 14 when the exercise monitoring apparatus is the sensor device 10.
Figure 17 illustrates a block diagram of the exercise monitoring apparatus according to an embodiment of the invention. As described above, the exercise monitoring apparatus may be sensor device 10, the user interface device 12, 14, or any other apparatus configured to monitor the heart activity measurement signals measured from the user's body during the physical exercise. The apparatus comprises a least one processor 60 and at least one memory 70 storing a computer program code 76. The computer program code 76 configures the processor to carry out embodiments of the invention, e.g. any one of the embodiments described above. The memory 70 may further store a training database 74 in which any parameters and performance metrics measured and/or computed during the exercise may be stored. The memory 70 may further store any thresholds 72 and/or any other parameters or criteria used in the embodiments described above.
The apparatus may further comprise a communication circuitry 52 providing the apparatus with communication capability. The communication circuitry may support any wired or wireless communication technique, e.g. Bluetooth, Bluetooth Low energy, IEEE 802.15, IEEE 802.1 1 , W.I.N. D, ANT by Dynastream, or any other radio or induction-based communication technique. Depending on the embodiment, the apparatus may further comprise at least one sensor 50 configured to measure the heart activity of the user 1 1 . The sensor(s) may comprise the above-described electrodes and appropriate circuitry to process the heart activity measurement signals. Depending on the embodiment, the apparatus may further comprise the user interface 54 for user interaction. The user interface 54 may comprise an output device and an input device. The output device may comprise a display unit (e.g. a liquid crystal display) and the input device may comprise one or more buttons or keys or a touch-sensitive display.
The processor 60 may comprise one or more sub-circuitries 62 to
69 configured to carry out the embodiments of the invention. The sub- circuitries 62 to 69 may be physical circuitries in the processor 60, or they may be realized by separate computer program modules, and the at least partially the same physical circuitries of the processor may carry out the operations of different modules 62 to 69.
The processor 60 may receive the heart activity measurement signal from the at least one sensor 50 or through the communication circuitry 52. The processor may comprise a phase extraction circuitry 62 configured to extract the phase component from the heart activity measurement signal and output the extracted phase component for further analysis. The processor 60 may further comprise a QRS detection circuitry 64 configured to detect the QRS complex waveform from the heart activity measurement signal. The operation of the QRS detection circuitry 64 may be based on detecting the R wave, for example. The QRS detection circuitry 64 or the processor 60 may then compute various performance metrics from the detected QRS waveforms, e.g. the heart rate, heart rate variability, energy consumption, and/or exertion level.
The processor 60 may comprise a QRS phase detection circuitry 66 configured to monitor the phase of the QRS complex waveform from the phase component received from the phase extraction circuitry 62, as described above in connection with Figures 1 1 to 15. The QRS phase detection circuitry 66 may be configured to carry out at least some of the actions on the basis of the detected phase of the QRS complex waveform, as described above. For example, the QRS phase detection circuitry may select an optimal measurement configuration (an optimal set of electrodes to provide the heart activity measurement signal) or control the user interface 54 to output an instruction for the user to adjust the positioning of the electrodes, e.g. to adjust the strap comprising the electrodes.
The processor 60 may comprise an interference detection circuitry 67 configured to determine the presence of the interference signal components in the heart activity measurement signal and control the elimination of the interference signal components from the analysis of the heart activity measurement signal. The interference detection circuitry may carry out the process described above in connection with Figures 7A to 8, and the interference detection circuitry may output the detected timings of the interference signal components to the QRS detection circuitry 64 such that the QRS detection circuitry 64 may eliminate any signal components having the timing received from the interference detection circuitry 67. In another embodiment, the interference detection circuitry may receive the heart activity measurement signal before it is input to the QRS detection circuitry 64, remove the interference signal components from the heart activity measurement signal, and output the interference-suppressed heart activity measurement signal to the QRS detection circuitry 64.
The processor 60 may further comprise a respiratory rate detection circuitry 68 configured to determine the user's respiratory rate from the periodicity of the phase component, as described above in connection with Figures 5 and 6.
The processor may further comprise a phase deviation detection circuitry 69 configured to monitor the phase deviation of the phase component. The phase deviation detection circuitry may carry out any one of the embodiments described above in connection with Figures 9A, 9B, 10, and 16, and carry out a corresponding action. For example, the phase deviation detection circuitry 69 may compute the correction factor for use in computation of the performance metric or the heart rate variability in the QRS detection circuitry 64, or the phase deviation detection circuitry 69 may output an instruction for the user to moisten the electrodes.
As used in this application, the term 'circuitry' refers to all of the following: (a) hardware-only circuit implementations such as implementations in only analog and/or digital circuitry; (b) combinations of circuits and software and/or firmware, such as (as applicable): (i) a combination of processor(s) or processor cores; or (ii) portions of processor(s)/software including digital signal processor(s), software, and at least one memory that work together to cause an apparatus to perform specific functions; and (c) circuits, such as a microprocessor(s) or a portion of a microprocessor(s), that require software or firmware for operation, even if the software or firmware is not physically present.
This definition of 'circuitry' applies to all uses of this term in this application. As a further example, as used in this application, the term "circuitry" would also cover an implementation of merely a processor (or multiple processors) or portion of a processor, e.g. one core of a multi-core processor, and its (or their) accompanying software and/or firmware. The term "circuitry" would also cover, for example and if applicable to the particular element, a baseband integrated circuit, an application-specific integrated circuit (ASIC), and/or a field-programmable grid array (FPGA) circuit for the apparatus according to an embodiment of the invention.
The processes or methods described in Figures 4 to 8 may also be carried out in the form of a computer process defined by a computer program. The computer program may be in source code form, object code form, or in some intermediate form, and it may be stored in some sort of carrier, which may be any entity or device capable of carrying the program. Such carriers include transitory and/or non-transitory computer media, e.g. a record medium, computer memory, read-only memory, electrical carrier signal, telecommunications signal, and software distribution package. Depending on the processing power needed, the computer program may be executed in a single electronic digital processing unit or it may be distributed amongst a number of processing units.
The present invention is applicable to exercise monitoring systems described above but also to other suitable exercise monitoring systems. The technology may evolve over time and the development may require extra changes to the described embodiments. Therefore, all words and expressions should be interpreted broadly and they are intended to illustrate, not to restrict, the embodiments. It will be obvious to a person skilled in the art that, as technology advances, the inventive concept can be implemented in various ways. The invention and its embodiments are not limited to the examples described above but may vary within the scope of the claims.

Claims

Claims
1 . An apparatus comprising:
at least one processor; and
at least one memory including a computer program code, wherein the at least one memory and the computer program code are configured, with the at least one processor, to cause the apparatus to: acquire a heart activity measurement signal of a user during a physical exercise performed by the user, wherein the heart activity measurement signal characterizes electric activity of a heart measured by at least one electrode pair in contact with the user's skin; monitor a phase of the heart activity measurement signal; and determine an action to perform on the basis of the phase of the heart activity measurement signal and performing said action.
2. The apparatus of claim 1 , wherein the at least one memory and the computer program code are configured, with the at least one processor, to cause the apparatus to determine a physiological parameter of the user from the phase of the heart activity measurement signal.
3. The apparatus of claim 2, wherein the at least one memory and the computer program code are configured, with the at least one processor, to cause the apparatus to: determine a periodicity of the phase of the heart activity measurement signal; and determine a respiratory rate of the user from the periodicity of the phase of the heart activity measurement signal.
4. The apparatus of any preceding claim, wherein the at least one memory and the computer program code are configured, with the at least one processor, to cause the apparatus to: determining interference signal components in the acquired heart activity signal on the basis of the phase of the heart activity measurement signal; and eliminating the determined interference signal components from further analysis of the heart activity measurement signal.
The apparatus of claim 4, wherein the at least one memory and the computer program code are configured, with the at least one processor, to cause the apparatus to: determine an average level of the phase of the heart activity measurement signal; determine a timing of phase samples of the heart activity measurement signal that deviate from the average level more than a predefined threshold; and eliminate signal components having said determined timing from further analysis of the heart activity signal.
The apparatus of claim 5, wherein the at least one memory and the computer program code are configured, with the at least one processor, to cause the apparatus to use as the average level a mean or a median of the phase of the heart activity measurement signal and a tolerance zone above and/or below the mean or median.
The apparatus of any preceding claim, wherein the at least one memory and the computer program code are configured, with the at least one processor, to cause the apparatus to: compute a deviation of the phase of the heart activity measurement signal; compute at least one correction factor from the deviation of the phase of the heart activity measurement signal; and compute a performance metric from the heart activity measurement signal by using the at least one correction factor.
8. The apparatus of claim 7, wherein the at least one memory and the computer program code are configured, with the at least one processor, to cause the apparatus to: compute variability of R-R intervals from the heart activity measurement signal; and compute the performance metric from the variability of the R-R intervals by using the at least one correction factor.
9. The apparatus of any preceding claim, wherein the at least one memory and the computer program code are configured, with the at least one processor, to cause the apparatus to determine a phase of a QRS complex waveform of the heart activity measurement signal from the phase of the heart activity measurement signal and perform said action on the basis of phase of the QRS complex waveform.
10. The apparatus of claim 9, wherein the at least one memory and the computer program code are configured, with the at least one processor, to cause the apparatus to: acquire at least a second heart activity measurement signal of the user during the physical exercise, wherein the second heart activity measurement signal is measured by at least one electrode pair not used for measuring said heart activity signal; determine beforehand at least one phase of the heart activity measurement signal that results in a maximal absolute value of an R wave amplitude in QRS complex waveforms of the heart activity measurement signal; compute phases of the heart activity measurement signals and select for further analysis a heart activity measurement signal that has its phase of the QRS complex waveform closest to the determined at least one phase of the QRS complex waveform that results in the maximal absolute value of the R wave amplitude.
1 1 . The apparatus of claim 10, wherein the at least one memory and the computer program code are configured, with the at least one processor, to cause the apparatus to determine the at least one phase of the QRS complex waveform that results in the maximal absolute value of the R wave from a design of a signal processing algorithm applied to the heart activity measurement signal when computing the phase of the QRS complex waveform.
12. The apparatus of any preceding claim, wherein the at least one memory and the computer program code are configured, with the at least one processor, to cause the apparatus to output, as said action, an instruction for the user to adjust at least one electrode measuring the heart activity data.
13. The apparatus of claim 12, wherein the at least one memory and the computer program code are configured, with the at least one processor, to cause the apparatus to: compute a deviation of the phase of the QRS complex waveform; detect that the deviation exceeds a predetermined threshold; in response to said detecting, output the instruction for the user to adjust the at least one electrode.
14. The apparatus of claim 13, wherein the instruction instructs the user to moisten the at least one electrode.
15. The apparatus of any preceding claim 12 to 14, wherein the at least one memory and the computer program code are configured, with the at least one processor, to cause the apparatus to: determine beforehand at least one phase of the QRS complex waveform that results in a maximal absolute value of an R wave amplitude of the heart activity signal; determine whether or not the phase of the heart activity measurement signal is within a determined range from any phase of the QRS complex waveform that results in the maximal absolute value of the R wave; and upon determining that the phase of the QRS complex waveform outside the determined range, output the instruction for the user to adjust the at least one electrode.
16. The apparatus of claim 15, wherein the instruction instructs the user to adjust positioning of the at least one electrode with respect to the user's body.
17. The apparatus of any preceding claim, wherein the at least one memory and the computer program code are configured, with the at least one processor, to cause the apparatus to: compute an auxiliary signal approximating a wavelet transform of the heart activity signal; and compute the phase of the heart activity measurement signal by computing an argument of the auxiliary signal.
18. A method for processing a heart activity measurement signal, the method comprising in an exercise monitoring apparatus: acquiring the heart activity measurement signal of a user during a physical exercise performed by the user, wherein the heart activity measurement signal characterizes electric activity of a heart and is measured by at least one electrode pair in contact with the user's skin; monitoring a phase of the heart activity measurement signal; and determining an action to perform on the basis of the phase of the heart activity measurement signal and performing said action.
19. The method of claim 18, said action comprising determining a physiological parameter of the user from the phase of the heart activity measurement signal.
20. The method of claim 19, said determining the physiological parameter comprising: determining a periodicity of the phase of the heart activity measurement signal; and determining a respiratory rate of the user from the periodicity of the phase of the heart activity measurement signal.
21 . The method of any preceding claim 18 to 20, said action comprising: determining interference signal components in the acquired heart activity signal on the basis of the phase of the heart activity measurement signal; and eliminating the determined interference signal components from further analysis of the heart activity measurement signal.
22. The method of claim 21 , further comprising: determining an average level of the phase of the heart activity measurement signal; determining a timing of phase samples of the heart activity measurement signal that deviate from the average level more than a predefined threshold; and eliminating signal components having said determined timing from further analysis of the heart activity signal.
23. The method of claim 22, wherein the average level is defined by a mean or median of the phase of the heart activity measurement signal and a tolerance zone above and/or below the mean or median.
24. The method of any preceding claim 18 to 23, said action comprising: computing a deviation of the phase of the heart activity measurement signal; computing at least one correction factor from the deviation of the phase of the heart activity measurement signal; and computing a performance metric from the heart activity measurement signal by using the at least one correction factor.
25. The method of claim 24, said computing he performance metric comprising: computing variability of R-R intervals from the heart activity measurement signal; and computing the performance metric from the variability of the R-R intervals by using the at least one correction factor.
26. The method of any preceding claim 18 to 25, further comprising determining a phase of a QRS complex waveform of the heart activity measurement signal from the phase of the heart activity measurement signal and performing said action on the basis of the phase of the QRS complex waveform.
27. The method of claim 26, further comprising: acquiring at least a second heart activity measurement signal of the user during the physical exercise, wherein the second heart activity measurement signal is measured by at least one electrode pair not used for measuring said heart activity signal; determining beforehand at least one phase of the heart activity measurement signal that results in a maximal absolute value of an R wave amplitude in QRS complex waveforms of the heart activity measurement signal; computing phases of the heart activity measurement signals and selecting for further analysis a heart activity measurement signal that has its phase of the QRS complex waveform closest to the determined at least one phase of the QRS complex waveform that results in the maximal absolute value of the R wave amplitude.
28. The method of claim 27, wherein the at least one phase of the QRS complex waveform that results in the maximal absolute value of the R wave is determined from a design of a signal processing algorithm applied to the heart activity measurement signal when computing the phase of the QRS complex waveform.
29. The method of any preceding claim 18 to 28, wherein the action comprises outputting an instruction for the user to adjust at least one electrode measuring the heart activity data.
30. The method of claim 29, the action comprising: computing a deviation of the phase of the QRS complex waveform; detecting that the deviation exceeds a predetermined threshold; in response to said detecting, outputting the instruction for the user to adjust the at least one electrode.
31 . The method of claim 30, wherein the instruction instructs the user to moisten the at least one electrode.
32. The method of any preceding claim 29 to 31 , further comprising: determining beforehand at least one phase of the QRS complex waveform that results in a maximal absolute value of an R wave amplitude of the heart activity signal; determining whether or not the phase of the heart activity measurement signal is within a determined range from any phase of the QRS complex waveform that results in the maximal absolute value of the R wave; and upon determining that the phase of the QRS complex waveform outside the determined range, outputting the instruction for the user to adjust the at least one electrode.
33. The method of claim 32, wherein the instruction instructs the user to adjust positioning of the at least one electrode with respect to the user's body.
34. The method of any preceding claim 18 to 33, further comprising: computing an auxiliary signal approximating a wavelet transform of the heart activity signal; and computing the phase of the heart activity measurement signal by computing an argument of the auxiliary signal.
35. An apparatus, comprising means for carrying out the method according to any preceding claim 18 to 34.
36. A computer program product embodied on a distribution medium readable by a computer and comprising program instructions which, when loaded into an apparatus, execute the method according to any preceding claim 18 to 34.
PCT/FI2013/050175 2013-02-14 2013-02-14 Improvements in heart activity monitoring during physical exercise WO2014125159A1 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
EP22217142.3A EP4179966A1 (en) 2013-02-14 2013-02-14 Improvements in heart activity monitoring during physical exercise
US14/767,225 US11534075B2 (en) 2013-02-14 2013-02-14 Heart activity monitoring during physical exercise
PCT/FI2013/050175 WO2014125159A1 (en) 2013-02-14 2013-02-14 Improvements in heart activity monitoring during physical exercise
EP13709954.5A EP2956051B1 (en) 2013-02-14 2013-02-14 Improvements in heart activity monitoring during physical exercise
US17/992,625 US20230091163A1 (en) 2013-02-14 2022-11-22 Heart activity monitoring during physical exercise

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/FI2013/050175 WO2014125159A1 (en) 2013-02-14 2013-02-14 Improvements in heart activity monitoring during physical exercise

Related Child Applications (2)

Application Number Title Priority Date Filing Date
US14/767,225 A-371-Of-International US11534075B2 (en) 2013-02-14 2013-02-14 Heart activity monitoring during physical exercise
US17/992,625 Continuation US20230091163A1 (en) 2013-02-14 2022-11-22 Heart activity monitoring during physical exercise

Publications (1)

Publication Number Publication Date
WO2014125159A1 true WO2014125159A1 (en) 2014-08-21

Family

ID=47891765

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FI2013/050175 WO2014125159A1 (en) 2013-02-14 2013-02-14 Improvements in heart activity monitoring during physical exercise

Country Status (3)

Country Link
US (2) US11534075B2 (en)
EP (2) EP2956051B1 (en)
WO (1) WO2014125159A1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016166757A1 (en) * 2015-04-14 2016-10-20 LifeWatch Technologies, Ltd. Alignment of a detachable monitoring device and a monitoring device
EP3419519A4 (en) * 2016-06-15 2019-04-17 Samsung Electronics Co., Ltd. Improving performance of biological measurements in the presence of noise
US10390764B2 (en) 2015-07-16 2019-08-27 Samsung Electronics Company, Ltd. Continuous stress measurement with built-in alarm fatigue reduction features

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050222513A1 (en) * 2004-03-30 2005-10-06 Hadley David M Methods for quantifying the morphology and amplitude of cardiac action potential alternans
US20100137727A1 (en) * 2008-11-21 2010-06-03 Massachusetts Institute Of Technology Extraction of fetal cardiac signals
US20110137191A1 (en) * 2008-06-02 2011-06-09 Polar Electro Oy Method and Apparatus in Connection with Exercise
US20120197148A1 (en) * 2010-08-05 2012-08-02 Jacob Levitan Heart rate variability sensor

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5025795A (en) * 1989-06-28 1991-06-25 Kunig Horst E Non-invasive cardiac performance monitoring device and method
US7623912B2 (en) * 2002-09-19 2009-11-24 Ramot At Tel Aviv University Ltd. Method, apparatus and system for characterizing sleep
WO2012137213A1 (en) * 2011-04-05 2012-10-11 Neurokeeper Technologies Ltd. System and method for detecting neurological deterioration
EP2589332A1 (en) * 2011-11-03 2013-05-08 Imec System and method for the analysis of electrocardiogram signals
EP2879579A1 (en) * 2012-08-01 2015-06-10 Draeger Medical Systems, Inc. System and method for measuring contact impedance of an electrode

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050222513A1 (en) * 2004-03-30 2005-10-06 Hadley David M Methods for quantifying the morphology and amplitude of cardiac action potential alternans
US20110137191A1 (en) * 2008-06-02 2011-06-09 Polar Electro Oy Method and Apparatus in Connection with Exercise
US20100137727A1 (en) * 2008-11-21 2010-06-03 Massachusetts Institute Of Technology Extraction of fetal cardiac signals
US20120197148A1 (en) * 2010-08-05 2012-08-02 Jacob Levitan Heart rate variability sensor

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
MOODY G B ET AL: "Derivation of respiratory signals from multi-lead ECGs", PROCEEDINGS OF THE COMPUTERS IN CARDIOLOGY MEETING. LINKOPING, SWEDEN, SEPT. 8 - 11, 1985; [PROCEEDINGS OF THE MEETING ON COMPUTERS IN CARDIOLOGY], WASHINGTON, IEEE COMP. SOC. PRESS, US, vol. MEETING 12, 8 September 1985 (1985-09-08), pages 113 - 116, XP002962678 *

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016166757A1 (en) * 2015-04-14 2016-10-20 LifeWatch Technologies, Ltd. Alignment of a detachable monitoring device and a monitoring device
US10390764B2 (en) 2015-07-16 2019-08-27 Samsung Electronics Company, Ltd. Continuous stress measurement with built-in alarm fatigue reduction features
US10456088B2 (en) 2015-07-16 2019-10-29 Samsung Electronics Company, Ltd. Performance of biological measurements in the presence of noise
US10478131B2 (en) 2015-07-16 2019-11-19 Samsung Electronics Company, Ltd. Determining baseline contexts and stress coping capacity
EP3419519A4 (en) * 2016-06-15 2019-04-17 Samsung Electronics Co., Ltd. Improving performance of biological measurements in the presence of noise

Also Published As

Publication number Publication date
US20160000336A1 (en) 2016-01-07
EP2956051C0 (en) 2023-06-07
EP2956051B1 (en) 2023-06-07
EP4179966A1 (en) 2023-05-17
US11534075B2 (en) 2022-12-27
EP2956051A1 (en) 2015-12-23
US20230091163A1 (en) 2023-03-23

Similar Documents

Publication Publication Date Title
US20230091163A1 (en) Heart activity monitoring during physical exercise
EP3478166B1 (en) On-demand heart rate estimation based on optical measurements
US10172519B2 (en) Biosignal transmitter, biosignal receiver, and method of transmitting and receiving biosignal
US8780786B2 (en) Method and apparatus for denoising of physiological signals
US20220365600A1 (en) Motion data processing method and motion monitoring system
EP2811908A1 (en) A microwave contactless heart rate sensor
CN108903929B (en) Heart rate detection correction method, device, storage medium and system
US9616291B2 (en) Wearable sports monitoring equipment with context determination capabilities and relating method
US11457865B2 (en) Wearable sports monitoring equipment for measuring heart rate or muscular activity and relating method
CN107028605A (en) Sensor information processing equipment
US20140194761A1 (en) Method and apparatus for monitoring biosignal with low power consumption
KR20170142208A (en) Robust Heart Rate Estimation
CN104902812B (en) For producing the improvement ECG computational methods of 12 lead ECG measured values from the device having less than 10 electrodes
JP6519344B2 (en) Heartbeat interval specifying program, heart beat interval specifying device, and heart beat interval specifying method
JP6440137B1 (en) Respiratory state estimation device, respiratory state estimation method, and program recording medium
JP2020188963A (en) Electrocardiographic waveform estimation device
US11116427B2 (en) Breathing activity monitoring device, corresponding system and method
CN107088060A (en) Sensor information processing equipment
Shin et al. Two electrode based healthcare device for continuously monitoring ECG and BIA signals
RU2821773C1 (en) Method of processing user movement data and user movement monitoring system
US20180333075A1 (en) Respiratory rate measuring method and apparatus, and wearable device
He et al. TreMo: Continuous Vital Sign Monitoring Based on Subtle Intrinsic Tremors with COTS Mobile Devices
FI126164B (en) A wearable sports monitoring device for measuring heart or muscle activity and the associated method
CN116965800A (en) Respiratory state evaluation method based on electrocardiographic data
JP2012065757A (en) Cardiac potential sensor

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 13709954

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 2013709954

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 14767225

Country of ref document: US

NENP Non-entry into the national phase

Ref country code: DE